Interestingly, we also found that upregulation of ATP6AP1 was found among molecular subtypes of breast cancer specifically in luminal subtypes (Fig. 2d), which were known with poor chemotherapy response in breast cancer [26]. Here, ATP6AP1 is linked to breast carcinoma.